Browse Pet Safety Reports
33,223 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 33,223 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 33,223 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 30, 2024 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Hind limb ataxia; Lateral recumbency; Dilated pupils; Abnormal pupil light re... | Euthanized |
| Mar 30, 2024 | Cat | Domestic Shorthair | Florfenicol; Mometasone Furoate; Terb... | Third eyelid protrusion; Not eating; Constricted pupils; Ataxia; Head tilt - ... | Ongoing |
| Mar 30, 2024 | Dog | Poodle (unspecified), Dog (... | Carprofen | Ataxia; Lethargy (see also Central nervous system depression in Neurological)... | Euthanized |
| Mar 30, 2024 | Dog | Terrier - Bull - American P... | Bedinvetmab | Disorientation; Stumbling gait; Not himself/herself; Decreased appetite; Ataxia | Recovered/Normal |
| Mar 29, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Hind limb ataxia | Ongoing |
| Mar 29, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine | Shaking; Difficulty standing; Ataxia; Anaphylaxis | Recovered/Normal |
| Mar 29, 2024 | Dog | Chihuahua | Fluralaner 13.64% 12-Week Chew | Anorexia; Emesis (multiple); Ataxia; Generalised weakness; Circling - neurolo... | Ongoing |
| Mar 29, 2024 | Dog | Boxer (German Boxer) | Galliprant | Ataxia | Recovered/Normal |
| Mar 29, 2024 | Dog | Retriever - Labrador | Fluralaner 13.64% 12-Week Chew | Staggering; Hind limb ataxia | Recovered/Normal |
| Mar 29, 2024 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Limb weakness; Difficulty standing; Ataxia; Knuckling; Limb non-weight bearin... | Ongoing |
| Mar 29, 2024 | Dog | Boxer (German Boxer), Terri... | Bedinvetmab | Ataxia | Recovered/Normal |
| Mar 29, 2024 | Dog | Pointing Dog - German Short... | Bedinvetmab | Ataxia; Circling - behavioural disorder (see also Neurological disorders); La... | Recovered/Normal |
| Mar 29, 2024 | Cat | Domestic Shorthair | Oclacitinib Maleate | Ataxia; Lethargy (see also Central nervous system depression in Neurological) | Outcome Unknown |
| Mar 29, 2024 | Cat | Domestic Shorthair | Methylprednisolone Acetate | Hind limb ataxia; Lateral recumbency; Dilated pupils; Abnormal pupil light re... | Euthanized |
| Mar 29, 2024 | Dog | Sheepdog - Shetland | Bedinvetmab | Ataxia; Impaired proprioception; Vomiting; Drooling; Elevated alanine aminotr... | Died |
| Mar 28, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Death by euthanasia; Not eating; Vomiting; Hot spot (pyotraumatic dermatitis)... | Euthanized |
| Mar 28, 2024 | Dog | Lhasa Apso | Sarolaner | Hind limb ataxia; Drug dose administration interval too short; Overdose | Ongoing |
| Mar 28, 2024 | Dog | Shiba Inu | Bedinvetmab | Ataxia; Staring | Ongoing |
| Mar 28, 2024 | Dog | Bulldog - French | Bedinvetmab | Weakness; Ataxia; Pruritus; Dermatitis; Intervertebral disc disease; Abnormal... | Euthanized |
| Mar 28, 2024 | Dog | Ridgeback - Rhodesian | Bedinvetmab | Muscle weakness NOS; Behavioural disorder NOS; Head tilt - neurological disor... | Euthanized |
| Mar 28, 2024 | Dog | Crossbred Canine/dog | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Ataxia | Outcome Unknown |
| Mar 28, 2024 | Dog | Retriever - Chesapeake Bay | Bedinvetmab | Ataxia; Weakness; Unable to walk; Elevated renal parameters | Ongoing |
| Mar 28, 2024 | Dog | Ridgeback - Rhodesian | Galliprant | Muscle weakness NOS; Behavioural disorder NOS; Head tilt - neurological disor... | Ongoing |
| Mar 27, 2024 | Dog | Retriever - Golden, Poodle ... | Bedinvetmab | Cyanotic mucous membranes; Ataxia; Dry mucous membrane; Recumbency; Seizure N... | Euthanized |
| Mar 27, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Ataxia; Vertical nystagmus; Proprioception loss | Ongoing |
| Mar 27, 2024 | Dog | Basenji | Spinosad; Milbemycin Oxime | Lethargy (see also Central nervous system depression in Neurological); Ataxia | Ongoing |
| Mar 27, 2024 | Dog | Retriever - Labrador, Siber... | Bedinvetmab | Intentional misuse; Lameness; Ataxia; Musculoskeletal disorder NOS; Limb weak... | Ongoing |
| Mar 27, 2024 | Dog | Shepherd (unspecified) | Bedinvetmab | Nystagmus; Ataxia; Claw / hoof / nail disorder NOS | Outcome Unknown |
| Mar 26, 2024 | Cat | Cat (unknown) | Pyrantel Embonate, Praziquantel | Ataxia; Vomiting; Elevated temperature | Ongoing |
| Mar 26, 2024 | Dog | Collie (unspecified), Dog (... | Bedinvetmab | Ataxia; Decreased activity; Head down; Arched back; Proprioception deficit; H... | Ongoing |
| Mar 26, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Ataxia; Proprioception loss; Urine leakage; Faecal incontinence; Decreased ap... | Ongoing |
| Mar 26, 2024 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Ataxia; Polyuria; Polydipsia; Lethargy (see also Central nervous system depre... | Recovered/Normal |
| Mar 26, 2024 | Dog | Hound (unspecified), Dog (u... | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Ataxia... | Outcome Unknown |
| Mar 26, 2024 | Dog | Retriever - Labrador | Grapiprant | Ataxia; Proprioception loss; Urine leakage; Faecal incontinence; Decreased ap... | Ongoing |
| Mar 26, 2024 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Urinary incontinence; Difficulty going up/down stairs; Lethargy (see also Cen... | Outcome Unknown |
| Mar 25, 2024 | Horse | Tennessee Walking Horse | Pergolide Mesylate | Ataxia; Head down | Recovered/Normal |
| Mar 25, 2024 | Dog | Chihuahua | Bedinvetmab | Ataxia | Ongoing |
| Mar 25, 2024 | Dog | Chihuahua, Greyhound - Italian | Ivermectin; Pyrantel As Pamoate Salt | Head tilt - neurological disorder (see also Head tilt - ear disorder); Circli... | Outcome Unknown |
| Mar 24, 2024 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Decreased activity; Decreased appetite; Hind limb ataxia; Hind limb paralysis... | Ongoing |
| Mar 23, 2024 | Dog | Newfoundland | Bedinvetmab | Ataxia; Impaired vocalisation | Ongoing |
| Mar 23, 2024 | Dog | Deutsche Dogge, Great Dane,... | Bedinvetmab | Ataxia; Vocalisation | Outcome Unknown |
| Mar 23, 2024 | Dog | American Pit Bull Terrier | Trilostane | Decreased appetite; Lethargy (see also Central nervous system depression in N... | Outcome Unknown |
| Mar 23, 2024 | Dog | Beagle | Isoflurane | Lethargy (see also Central nervous system depression in Neurological); Ataxia... | Outcome Unknown |
| Mar 23, 2024 | Dog | Terrier (unspecified), Dog ... | Bedinvetmab | Death by euthanasia; Head tilt - neurological disorder (see also Head tilt - ... | Euthanized |
| Mar 23, 2024 | Cat | Domestic Shorthair | Florfenicol; Mometasone Furoate; Terb... | Vomiting; Hiding; Lethargy (see also Central nervous system depression in Neu... | Outcome Unknown |
| Mar 23, 2024 | Dog | Saint Bernard Dog | Bedinvetmab | Ataxia; Weakness; Lethargy (see also Central nervous system depression in Neu... | Ongoing |
| Mar 23, 2024 | Dog | Great Pyrenees | Bedinvetmab | Hind limb ataxia | Ongoing |
| Mar 23, 2024 | Dog | Retriever - Golden | Bedinvetmab | Faecal incontinence; Vomiting; Hind limb ataxia; Diarrhoea; Bloated stomach; ... | Euthanized |
| Mar 22, 2024 | Dog | Terrier (unspecified), Pood... | Cefovecin | Ataxia; Elevated renal parameters; Seizure NOS; Focal seizure; Clenched jaw; ... | Ongoing |
| Mar 22, 2024 | Dog | Shepherd Dog - Australian | Florfenicol; Mometasone Furoate; Terb... | Hind limb ataxia; Eosinopenia; Lymphopenia; Hypoalbuminaemia; Falling; Stumbl... | Recovered with Sequela |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.